Trials / Completed
CompletedNCT03819959
Metabolomics Study on Intensive Care Acquired Muscle Weakness in Polytrauma
Metabolomics Pilot Study on Intensive Care Acquired Muscle Weakness in Polytrauma (MIRACLE-II Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Technical University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this mono-center pilot trial, polytrauma patients admitted to intensive care will be included. Investigators are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing. Aim of the study is to investigate (1) changes of the blood metabolome in patients with ICUAW (intensive care unit acquired weakness) and (2) identify metabolic components who are responsible for ICUAW or can be used as marker for ICUAW.
Conditions
- Metabolomics
- Critical Care
- Critical Illness
- Critical Illness Myopathy
- Critical Illness Polyneuropathy
- Intensive Care (ICU) Myopathy
- Muscle Weakness
Timeline
- Start date
- 2019-03-24
- Primary completion
- 2020-04-22
- Completion
- 2020-04-22
- First posted
- 2019-01-29
- Last updated
- 2020-10-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03819959. Inclusion in this directory is not an endorsement.